The molecular formula of oxybutynin chloride is C Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.If you miss a dose of this medicine, take it as soon as possible. Protect from moisture and humidity.For more information call 1-888-235-BION or 1-888-235-2466. This medicine is usually taken with water on an empty stomach. These highlights do not include all the information needed to use OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. This means your doctor will need to get approval from your insurance company before your insurance company will pay for the prescription.There are other drugs available to treat your condition. Be sure to tell your doctor about all medications, vitamins, or herbs you’re taking.
If you are a consumer or patient please visit It comes with serious risks if you don’t take it as prescribed.If you think you’ve taken too much of this drug, call your doctor or local poison control center. Reproduction studies with oxybutynin chloride in the mouse, rat, hamster, and rabbit showed no evidence of impaired fertility.The efficacy results for the three controlled trials are presented in the following Tables 4, 5, and 6 and Figures 3, 4, and 5.Oxybutynin chloride extended-release tablets, USP are available in three dosage strengths, 5 mg (white), 10 mg (white), and 15 mg (white) and are round, biconvex, film-coated tablets, debossed with “X1”, “X2”, or “X3” and plain on the other side.
Both enantiomers of oxybutynin are highly bound (>99%) to plasma proteins. Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine. Its metabolic products include phenylcyclohexylglycolic acid, which is pharmacologically inactive, and desethyloxybutynin, which is pharmacologically active. The mean pharmacokinetic parameters for R-and S-oxybutynin are summarized in Table 2. Including incontinence or the loss of bladder control, or the frequent need of a person to urinate.It belongs to a particular group of medication called antispasmodics, which helps reduce the spasms of the muscles in the bladder.

Side Effects. To report SUSPECTED ADVERSE REACTIONS, contact Bionpharma Inc. at 1-888-235-BION or 1-888-­235-2466 or FDA at 1-800-FDA-1088 or Table 1: Adverse Drug Reactions Reported by 1% of Oxybutynin Chloride Extended-Release Tablets-treated Adult Subjects in Five Double-blind, Controlled Clinical Trials of Oxybutynin Chloride Extended-Release TabletsGeneral Disorders and Administration Site ConditionsGeneral disorders and administration site conditions: General Disorders and Administration Site Conditions:Table 2: Mean (SD) R- and S-Oxybutynin Pharmacokinetic Parameters Following a Single Dose of Oxybutynin Chloride Extended-Release Tablets 10 mg (n=43)Figure 1: Mean R-oxybutynin plasma concentrations following a single dose of oxybutynin chloride extended-release tablets 10 mg and oxybutynin 5 mg administered every 8 hours (n=23 for each treatment).Table 3: Mean ± SD R- and S-Oxybutynin and R- and S-Desethyloxybutynin Pharmacokinetic Parameters in Children Aged 5 to 15 Following Administration of 5 to 20 mg Oxybutynin Chloride Extended-Release Tablets Once Daily (n=19), All Available Data Normalized to an Equivalent of Oxybutynin Chloride Extended-Release Tablets 5 mg Once DailyFigure 2: Mean steady state (± SD) R-oxybutynin plasma concentrations following administration of 5 to 20 mg oxybutynin chloride extended-release tablets once daily in children aged 5 to 15.